美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

iShares U.S. Pharmaceuticals ETF

102.27

+1.041.03%

成交量：6.41萬

成交額：653.99萬

市值：16.36億

市盈率：9.53

高：102.51

開：102.11

低：101.67

收：101.23

52周最高：108.66

52周最低：69.02

股本：1,600.00萬

流通股本：1,600.00萬

量比：0.33

換手率：0.40%

股息：1.43

股息率：1.40%

每股收益(TTM):10.74

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

有報道稱阿波羅正就收購強生公司骨科業務部門進行談判，受此消息提振，強生股價上漲

強生骨科，買家浮出水面

赛柏蓝器械

強生骨科業務引阿波羅興趣，潛在200億美元交易推動盤前股價上漲1.2%

強生股價盤前上漲1.2%，此前有報道稱阿波羅全球管理公司有意收購強生旗下骨科業務，潛在交易估值約為200億美元。

強生Rybrevant聯合化療在EGFR外顯子20插入突變非小細胞肺癌中實現迄今報告最長的中位總生存期

強生：RYBREVANT聯合化療在EGFR外顯子20插入突變非小細胞肺癌中實現已報告的最長中位總生存期。

強生據報與阿波羅洽談約200億美元骨科業務交易

环球市场播报

傳阿波羅(APO.US)擬接盤強生(JNJ.US)骨科業務潛在交易估值近200億美元

據彭博社報導，阿波羅全球正就收購強生公司骨科業務部門進行談判

據彭博社報道，阿波羅全球正就收購強生公司骨科業務部門進行談判

據稱阿波羅正在洽談收購強生骨科業務部門。

禮來完成對Ataibeckley收購，加速推進難治性抑鬱症及其他精神健康疾病療法研發

無AI增長：八大精選股票

媒體-禮來公司憑藉GLP-1帶來的意外之財，將用於推進女性健康業務——彭博社

強生（JNJ）漲1.63% 新款雙周拋隱形眼鏡獲CE認證

默沙東帕博利珠單抗三陰性乳腺癌適應症人群擴展在華獲批

118款生物藥專利懸崖將至，中國藥企業迎戰MNC最大專利懸崖

Leerink Partners上調默克目標價至161美元

百時美施貴寶(BMY)股票9月8日盤中下跌3.25%：真相來了

TradingKey中文

諾華公司一款降膽固醇藥物在臨床試驗中失敗，Royalty Pharma股價下跌

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hant/stock/IHE/news?page=3"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IHE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IHE\",,,,,undefined,":{"symbol":"IHE","market":"US","secType":"STK","nameCN":"iShares U.S. Pharmaceuticals ETF","latestPrice":102.27,"timestamp":1789675200000,"preClose":101.23,"halted":0,"volume":64116,"delay":0,"changeRate":0.010273634298132885,"floatShares":16000000,"shares":16000000,"eps":10.735807,"marketStatus":"盤前交易","change":1.04,"latestTime":"09-18 05:53:58 EDT","open":102.11,"high":102.51,"low":101.665,"amount":6539863.801536,"amplitude":0.008347,"askPrice":114.08,"askSize":100,"bidPrice":91,"bidSize":100,"shortable":3,"etf":1,"ttmEps":10.735807,"tradingStatus":1,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1789738200000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":102.27,"sharesOutstanding":11650000,"nav":101.172484,"aum":1654170113.4,"dividendRate":0.014,"bidAskSpread":0.000502,"postHourTrading":{"tag":"盘后","latestPrice":102.27,"preClose":102.27,"latestTime":"19:58 EDT","volume":61,"amount":6257.771,"timestamp":1789689487850,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.3301136834418928,"impliedVol":0.0344,"impliedVolPercentile":0.068},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IHE\",,,,,undefined,":{"symbol":"IHE","floatShares":16000000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.3301136834418928,"shares":16000000,"dividePrice":1.4318,"high":102.51,"amplitude":0.008347,"preClose":101.23,"low":101.665,"week52Low":69.02,"pbRate":"--","week52High":108.66,"institutionHeld":0,"latestPrice":102.27,"eps":10.735807,"divideRate":0.014,"volume":64116,"delay":0,"ttmEps":10.735807,"open":102.11,"prevYearClose":84.83,"prevWeekClose":101.07,"prevMonthClose":103.64,"prevQuarterClose":99.01,"fiveDayClose":101.27,"twentyDayClose":108.16,"sixtyDayClose":94.12},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IHE\",params:#limit:5,,,undefined,":[{"date":"2026-09-15","symbol":"IHE","amount":0.278883,"announcedDate":"2026-09-14","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-15","defaultRemindTime":1789479000000,"name":"iShares U.S. Pharmaceuticals ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-18","payableDate":"2026-09-15","currency":"USD","dateTimestamp":1789444800000,"payDate":"2026-09-18"},{"date":"2026-06-15","symbol":"IHE","amount":0.284781,"announcedDate":"2026-06-12","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-15","defaultRemindTime":1781530200000,"name":"iShares U.S. Pharmaceuticals ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-18","payableDate":"2026-06-15","currency":"USD","dateTimestamp":1781496000000,"payDate":"2026-06-18"},{"date":"2026-03-17","symbol":"IHE","amount":0.284491,"announcedDate":"2026-03-16","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-17","defaultRemindTime":1773754200000,"name":"iShares U.S. Pharmaceuticals ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-20","payableDate":"2026-03-17","currency":"USD","dateTimestamp":1773720000000,"payDate":"2026-03-20"},{"date":"2025-12-16","symbol":"IHE","amount":0.585254,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"iShares U.S. Pharmaceuticals ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-19"},{"date":"2025-09-16","symbol":"IHE","amount":0.312397,"announcedDate":"2025-09-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-16","defaultRemindTime":1758029400000,"name":"iShares U.S. Pharmaceuticals ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-19","payableDate":"2025-09-16","currency":"USD","dateTimestamp":1757995200000,"payDate":"2025-09-19"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IHE\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-26","recordDate":"2016-09-28","paymentDate":"2016-09-30","value":0.315888,"currency":"USD"},{"executeDate":"2016-12-21","recordDate":"2016-12-23","paymentDate":"2016-12-28","value":0.33773,"currency":"USD"},{"executeDate":"2017-03-24","recordDate":"2017-03-28","paymentDate":"2017-03-30","value":0.358233,"currency":"USD"},{"executeDate":"2017-06-27","recordDate":"2017-06-29","paymentDate":"2017-06-30","value":0.91844,"currency":"USD"},{"executeDate":"2017-09-26","recordDate":"2017-09-27","paymentDate":"2017-09-29","value":0.449501,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IHE\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IHE\",pageSize:20,pageCount:3,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2667668250","title":"有報道稱阿波羅正就收購強生公司骨科業務部門進行談判，受此消息提振，強生股價上漲","url":"https://stock-news.laohu8.com/highlight/detail?id=2667668250","media":"路透中文","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667668250?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 19:28","pubTimestamp":1789385329,"startTime":"0","endTime":"0","summary":"BUZZ-有报道称阿波罗正就收购强生公司骨科业务部门进行谈判，受此消息提振，强生股价上涨9月14日-** 强生公司（JNJ.N）股价在盘前交易中上涨1.3%，报268.96美元** 据彭博社周五援引消息人士报道，阿波罗全球管理公司（APO.N）正就收购该公司骨科业务部门进行谈判（(link)），该交易估值可能接近200亿美元** 报道称，双方可能在数周内达成协议** 该部门2025年营收达93亿美","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nL4S4560SI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JNJ","IE0009355771.USD","VHT","FHLC","APO","IXJ","IYH","LU0882574055.USD","LU1291159041.SGD","IE00B3T34201.USD","IHE","GPZ","IE000BZT7R73.USD","LU0994945656.USD","IE00BFTCPJ56.SGD","SG9999002224.SGD","IE0000B7K699.USD","MEDX","PRVT","LU0943347566.SGD","SG9999013999.USD","LU0122379950.USD","LU2430703251.USD","GDOC","LU0098860793.USD","IE00B3PB1722.GBP","LU2347655156.SGD","IE000F7OJYX1.SGD","LU0345770308.USD","LU0124676726.USD","LU1043141123.HKD","LU2133065610.SGD","PJP","TRUH","LU1791807156.HKD","AAUM","FTXH","BK4184","BMED","XLV","IE00BBT3K403.USD","LU1929549753.HKD","RXL","LU1989771016.USD","LU2756315664.SGD","JDOC","LBO","LU0795875169.SGD","BK4135","IE0034235303.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667636436","title":"強生骨科，買家浮出水面","url":"https://stock-news.laohu8.com/highlight/detail?id=2667636436","media":"赛柏蓝器械","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667636436?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 19:10","pubTimestamp":1789384200,"startTime":"0","endTime":"0","summary":"Apollo盯上强生骨科近期，强生骨科业务剥离有了新进展。不过，这并不意味着强生骨科业务的最终剥离方式已经确定。截至目前，Apollo和强生均未对此事作出回应。自2025年10月公布分拆消息后，历经近一年推进，DePuy Synthes的潜在买家终于浮出水面。强生2025年年报显示，其骨科业务全年销售额为92.58亿美元，约占强生医疗科技收入的27%，同比增长1.1%。从业务表现来看，强生骨科仍处于增长态势。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-09-14/doc-iniruxuy4555032.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU1929549753.HKD","IYH","IHE","XLV","LU2023250330.USD","LU1894683348.USD","LU2756315664.SGD","LU1121112475.USD","LU1221951046.USD","LU2487616109.SGD","MEDX","LU2417539215.USD","VHT","LU2430703095.HKD","LU1674673428.USD","IE000SO60NU8.SGD","LU0820561818.USD","SG9999002232.USD","FHLC","LU1032955483.USD","LU2505996509.AUD","IE00B1BXHZ80.USD","LU0994945656.USD","LU0426412945.USD","LU1894683264.USD","PJP","LU1066053197.SGD","RXL","LU1023059063.AUD","IE00BSNM7G36.USD","IE0009355771.USD","GDOC","JDOC","IE00BVYPNW00.USD","IXJ","FTXH","LU1914381329.SGD","IE00BLSP4452.SGD","IE00B4R5TH58.HKD","LU0072461881.USD","LU2236285917.USD","TRUH","LU1280957306.USD","BMED","LU1989771016.USD","SG9999013999.USD","LU1291159041.SGD","LU2112291526.USD","LU1196500208.SGD","JNJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171745492","title":"強生骨科業務引阿波羅興趣，潛在200億美元交易推動盤前股價上漲1.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=1171745492","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171745492?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 16:18","pubTimestamp":1789373891,"startTime":"0","endTime":"0","summary":"据报道，强生公司的骨科业务部门吸引了阿波罗全球管理的关注，这一潜在交易估值或达200亿美元。受此消息提振，强生股价在盘前交易中上涨了1.2%。知情人士透露，私募股权巨头阿波罗已就收购强生骨科业务的可能性进行了初步接触。强生骨科业务涵盖创伤修复、关节置换、脊柱外科及运动医学等多个细分领域，在全球范围内拥有广泛的市场布局。截至发稿时，强生和阿波罗均未对此传闻发表官方评论。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0820562030.AUD","LU0689626769.HKD","LU1121112475.USD","IE0001KFT4U8.USD","LU1718418525.SGD","PRVT","LU1145028129.USD","BK4581","LU0985320562.USD","LU1280957306.USD","LU0210536198.USD","IE00BKVL7J92.USD","IHE","LU1032466523.USD","LU1023059063.AUD","LU0345770308.USD","FTXH","LU2236285917.USD","LU0106831901.USD","LU0964807845.USD","XLV","GPZ","LU2468319806.SGD","LU2417539215.USD","IE00B19Z3581.USD","IE0002270589.USD","LU0792757196.USD","LU0203345920.USD","TRUH","LU1506573853.SGD","LU1196500208.SGD","LU2129689431.USD","LU0345769631.USD","LU2756315318.SGD","LU1551013342.USD","LU1221951129.SGD","LU1668664300.SGD","BK4184","LU2023250330.USD","RXL","LU1629891620.HKD","IE00B3S45H60.SGD","LU1244550494.USD","LU2403377893.USD","LU0070217475.USD","LU1043141396.HKD","BK4559","LU1244550577.SGD","LU0472753341.HKD","GDOC","IE00B3PB1722.GBP","LU1551013425.SGD","LU0820561909.HKD","IE00BVYPNW00.USD","LU0234572021.USD","LU0203347892.USD","LU1585245621.USD","LU1914381329.SGD","LU0057025933.USD","JNJ","IYH","LU0787776722.HKD","LU0053666078.USD","SG9999001176.USD","LU0098860793.USD","IE0002141913.USD","IE00BJT1NW94.SGD","BK4585","LBO","LU1323610961.USD","LU2112291526.USD","LU2430703095.HKD","FHLC","LU2487616109.SGD","LU1057294990.SGD","LU2471134952.CNY","LU2750360997.AUD","BMED","BK4007","LU1074936037.SGD","LU1496350502.SGD","IE000BZT7R73.USD","LU2505996509.AUD","IE00B19Z3B42.SGD","LU0820561818.USD","IE00BJJMRZ35.SGD","LU0882574055.USD","SGXZ57979304.SGD","LU2750360641.GBP","IE0009355771.USD","IE00B775SV38.USD","IE00BSNM7G36.USD","LU0320765646.SGD","LU2430703251.USD","IE000MB6IJN5.SGD","LU2133065610.SGD","SGXZ80539844.SGD","LU2471134879.HKD","IE000SO60NU8.SGD","LU1059921491.USD","BK4504","LU1066051498.USD","LU0289739343.SGD","LU0432979614.USD","LU1061106388.HKD","LU0912757837.SGD","APO","LU2213496289.HKD","LU2505996681.GBP","SG9999013999.USD","LU1221951046.USD","LU0545562505.USD","LU0069063385.USD","LU2756315664.SGD","LU2089984988.USD","SG9999002224.SGD","LU1894683348.USD","LU1791807156.HKD","LU0943347566.SGD","BK4568","LU0345769128.USD","IE00B1BXHZ80.USD","VHT","LU0114720955.EUR","IE00BFXG1179.USD","LU0511384066.AUD","LU0795875086.SGD","LU1043141123.HKD","IE00BGHQF631.EUR","LU1066053197.SGD","LU1674673691.USD","LU1430594728.SGD","LU0210528500.USD","LU1894683264.USD","LU1674673428.USD","AAUM","IE00B4R5TH58.HKD","LU0289961442.SGD","LU0640476718.USD","LU2602419157.SGD","LU0466842654.USD","IE00BLSP4452.SGD","BK4534","LU1732799900.SGD","LU0124676726.USD","IE00BFTCPJ56.SGD","LU1267930813.SGD","IE000WAW04H5.SGD","LU0162691827.USD","IE00BN8TJ469.HKD","LU2471134523.USD","LU0289739699.SGD","LU2471134796.USD","LU0683600562.USD","LU1989771016.USD","IE0000B7K699.USD","LU2347655156.SGD","BK4532","IE000M9KFDE8.USD","LU0058720904.USD","LU1244550221.USD","IE000F7OJYX1.SGD","IE0034235303.USD","LU2430703178.SGD","LU1732800096.USD","IXJ","LU1778281490.HKD","LU2592432038.USD","LU0072461881.USD","MEDX","SG9999002232.USD","IE00BVYPNV92.GBP","JDOC","IE00BBT3K403.USD","LU0006061336.USD","LU0795875169.SGD","LU0234570918.USD","BK4588","LU0889566641.SGD","LU1032955483.USD","LU1162221912.USD","LU1935042991.SGD","IE00BDGV0183.EUR","LU1066051811.HKD","BK4592","LU0426412945.USD","LU2129689514.USD","IE00B3T34201.USD","SG9999001176.SGD","BK4135","LU1228905037.USD","LU1929549753.HKD","LU1261432733.SGD","LU2456880835.USD","PJP","SG9999001440.SGD","LU1228905540.USD","BK4533","LU0689472784.USD","IE00B7SZLL34.SGD","LU1291159041.SGD","IE00BLSP4239.USD","LU1066051225.USD","LU0994945656.USD","IE00B2B36J28.USD","LU0345770993.USD","LU1983299246.USD","IE00BZ1G4Q59.USD","LU2896262040.SGD","BK4550","LU0122379950.USD","LU2129689605.HKD","LU0426417589.USD","IE00B42XCP33.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667659843","title":"強生股價盤前上漲1.2%，此前有報道稱阿波羅全球管理公司有意收購強生旗下骨科業務，潛在交易估值約為200億美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2667659843","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667659843?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 16:18","pubTimestamp":1789373891,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0792757196.USD","LU0289739343.SGD","LU2592432038.USD","LU1585245621.USD","MEDX","IXJ","LU0882574055.USD","LU1066051225.USD","GDOC","LBO","LU1430594728.SGD","FTXH","IE00BN8TJ469.HKD","GPZ","IE00B42XCP33.USD","XLV","LU0889566641.SGD","JDOC","BK4585","IE00BKVL7J92.USD","LU1267930813.SGD","JNJ","LU2430703251.USD","LU1032466523.USD","LU1221951046.USD","LU2896262040.SGD","PRVT","VHT","LU0320765646.SGD","RXL","IE000BZT7R73.USD","PJP","LU0426412945.USD","LU2023250330.USD","IYH","IHE","TRUH","LU0070217475.USD","APO","LU1066053197.SGD","IE000WAW04H5.SGD","BK4184","FHLC","LU0345769128.USD","BK4559","LU1244550221.USD","IE0009355771.USD","IE00BDGV0183.EUR","AAUM","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120093998","title":"強生Rybrevant聯合化療在EGFR外顯子20插入突變非小細胞肺癌中實現迄今報告最長的中位總生存期","url":"https://stock-news.laohu8.com/highlight/detail?id=1120093998","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120093998?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 09:47","pubTimestamp":1789350464,"startTime":"0","endTime":"0","summary":"强生公司日前公布了一项重磅临床数据——其旗下药物Rybrevant与化疗联用，在携带EGFR外显子20插入突变的非小细胞肺癌患者中，取得了目前公开报告中最长的中位总生存期。EGFR外显子20插入突变，历来被视为治疗难点，可选方案有限且疗效欠佳。观察人士指出，这不仅能巩固Rybrevant在精准医疗版图中的地位，更可能重塑晚期非小细胞肺癌的一线治疗格局。强生能否借此在竞争激烈的肺癌药物市场中进一步扩大优势，值得持续跟踪。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BLSP4239.USD","LU1551013342.USD","LU2750360997.AUD","LU0289739699.SGD","LU0689472784.USD","LU1162221912.USD","LU1267930813.SGD","LU2133065610.SGD","LU0820562030.AUD","LU2471134796.USD","IE0001KFT4U8.USD","LU1506573853.SGD","LU0058720904.USD","LU1066051498.USD","SG9999002232.USD","LU1718418525.SGD","IE00BLSP4452.SGD","LU0345769128.USD","LU0345769631.USD","LU2213496289.HKD","LU2456880835.USD","LU1244550221.USD","LU0882574055.USD","LU0289961442.SGD","LU0787776722.HKD","MEDX","VHT","LU0072461881.USD","LU1066051225.USD","LU1280957306.USD","SGXZ80539844.SGD","BK4592","IE00B3T34201.USD","IE00BZ1G4Q59.USD","IXJ","LU1585245621.USD","LU1145028129.USD","IE00BSNM7G36.USD","LU0795875169.SGD","SGXZ57979304.SGD","IE0034235303.USD","LU0098860793.USD","JDOC","LU2896262040.SGD","IE00B19Z3581.USD","LU2417539215.USD","LU2347655156.SGD","IE000BZT7R73.USD","BK4532","LU1778281490.HKD","RXL","LU0069063385.USD","LU0943347566.SGD","LU0122379950.USD","LU1066051811.HKD","LU1551013425.SGD","BK4568","LU0053666078.USD","SG9999001176.SGD","LU2756315664.SGD","LU0792757196.USD","LU1023059063.AUD","LU1057294990.SGD","PJP","IE0009355771.USD","LU2023250330.USD","IE00B4R5TH58.HKD","LU1291159041.SGD","LU1261432733.SGD","IE00B42XCP33.USD","IE00BJT1NW94.SGD","LU2430703178.SGD","IE00BFXG1179.USD","LU0203347892.USD","LU2468319806.SGD","LU0345770993.USD","LU0114720955.EUR","BMED","IE00B19Z3B42.SGD","FTXH","BK4534","BK4533","LU1066053197.SGD","BK4581","LU1732799900.SGD","LU2471134952.CNY","LU2112291526.USD","LU0912757837.SGD","LU1032466523.USD","LU0057025933.USD","IE00BVYPNV92.GBP","LU0964807845.USD","XLV","IE00BBT3K403.USD","LU1674673691.USD","SG9999001176.USD","LU1221951046.USD","LU0234570918.USD","LU1894683348.USD","TRUH","IE00BGHQF631.EUR","IE00BVYPNW00.USD","IYH","LU0345770308.USD","LU2129689605.HKD","LU0210528500.USD","LU2592432038.USD","LU1935042991.SGD","JNJ","LU0466842654.USD","LU1121112475.USD","LU1074936037.SGD","IE00BFTCPJ56.SGD","LU0994945656.USD","LU2471134523.USD","LU0640476718.USD","LU0683600562.USD","LU0795875086.SGD","LU1629891620.HKD","IE0000B7K699.USD","LU1983299246.USD","LU2129689514.USD","LU1929549753.HKD","IHE","LU1244550494.USD","LU1496350502.SGD","BK4559","LU1989771016.USD","LU2471134879.HKD","BK4504","LU2756315318.SGD","IE000SO60NU8.SGD","LU0545562505.USD","LU0689626769.HKD","BK4550","LU1228905540.USD","SG9999001440.SGD","FHLC","LU2129689431.USD","BK4588","LU0234572021.USD","LU0426412945.USD","IE00BKVL7J92.USD","LU2430703095.HKD","IE00BN8TJ469.HKD","LU0432979614.USD","IE00B3PB1722.GBP","LU1674673428.USD","IE000MB6IJN5.SGD","LU0820561909.HKD","LU0985320562.USD","LU0889566641.SGD","LU1196500208.SGD","LU1732800096.USD","LU2403377893.USD","LU0162691827.USD","IE00B2B36J28.USD","LU1221951129.SGD","LU2505996509.AUD","LU2602419157.SGD","LU2487616109.SGD","LU0511384066.AUD","LU0124676726.USD","IE00B1BXHZ80.USD","LU0289739343.SGD","IE00BJJMRZ35.SGD","LU2750360641.GBP","LU1061106388.HKD","SG9999002224.SGD","LU1043141396.HKD","IE00B7SZLL34.SGD","SG9999013999.USD","IE00BDGV0183.EUR","IE000WAW04H5.SGD","LU0472753341.HKD","LU2505996681.GBP","LU1043141123.HKD","IE000M9KFDE8.USD","IE0002270589.USD","LU1430594728.SGD","LU1894683264.USD","LU0426417589.USD","BK4585","LU0070217475.USD","LU0210536198.USD","LU0820561818.USD","LU2430703251.USD","GDOC","LU1032955483.USD","LU1059921491.USD","LU1244550577.SGD","BK4007","IE0002141913.USD","LU0203345920.USD","LU1228905037.USD","LU0320765646.SGD","IE000F7OJYX1.SGD","LU1914381329.SGD","LU2236285917.USD","LU2089984988.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667631840","title":"強生：RYBREVANT聯合化療在EGFR外顯子20插入突變非小細胞肺癌中實現已報告的最長中位總生存期。","url":"https://stock-news.laohu8.com/highlight/detail?id=2667631840","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667631840?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 09:46","pubTimestamp":1789350398,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE00BLSP4239.USD","LU1145028129.USD","IHE","LU0122379950.USD","LU2592432038.USD","VHT","BK4559","IE0001KFT4U8.USD","BK4568","BMED","LU0683600562.USD","LU0053666078.USD","IE00BDGV0183.EUR","LU2471134523.USD","LU0426417589.USD","GDOC","LU2133065610.SGD","LU0072461881.USD","LU2430703095.HKD","MEDX","IE0000B7K699.USD","LU0511384066.AUD","IYH","BK4533","LU1244550494.USD","RXL","JNJ","LU1894683264.USD","BK4550","IXJ","LU0985320562.USD","LU1674673691.USD","IE00BFTCPJ56.SGD","LU1032466523.USD","XLV","IE00BVYPNV92.GBP","LU2089984988.USD","LU2471134879.HKD","FTXH","FHLC","LU1935042991.SGD","TRUH","PJP","IE00B3T34201.USD","LU1280957306.USD","BK4588","IE00BGHQF631.EUR","LU0820561909.HKD","IE0002141913.USD","JDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667329689","title":"強生據報與阿波羅洽談約200億美元骨科業務交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2667329689","media":"环球市场播报","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667329689?lang=zh_tw&edition=fundamental","pubTime":"2026-09-13 14:27","pubTimestamp":1789280820,"startTime":"0","endTime":"0","summary":"据知情人士消息，阿波罗全球管理公司正洽谈收购强生旗下以DePuy Synthes为主体的骨科业务，交易金额约为200亿美元。知情人士称，强生与阿波罗正在就出售展开谈判，但双方仍可能无法达成交易，强生也可能选择其他买家。强生和阿波罗目前均未公布交易安排。以当前报道的约200亿美元交易金额计算，潜在售价与强生当年的实际收购价格大致相当，但期间业务范围、财务表现和资产构成已经发生变化。此次潜在出售也是强生持续调整业务组合的一部分。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-09-13/doc-inirskha4546532.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0057025933.USD","LU2089984988.USD","IYH","IE00B4R5TH58.HKD","LU0545562505.USD","LU2430703251.USD","LU0122379950.USD","LU0889566641.SGD","LU1066053197.SGD","LU2896262040.SGD","IE00B42XCP33.USD","RXL","LU0792757196.USD","LU0795875086.SGD","LU2213496289.HKD","IE00B19Z3581.USD","LU0795875169.SGD","MEDX","LU0689472784.USD","PJP","LU1935042991.SGD","LU2129689431.USD","VHT","LU0820561909.HKD","IE00BFXG1179.USD","LU2471134523.USD","FHLC","LU0640476718.USD","LU1732800096.USD","IE000F7OJYX1.SGD","IHE","BMED","LU1430594728.SGD","XLV","LU2023250330.USD","LU2456880835.USD","JNJ","IE00BVYPNV92.GBP","LU1059921491.USD","FTXH","IXJ","JDOC","LU1496350502.SGD","GDOC","TRUH","LU0426412945.USD","LU1228905540.USD","LU1778281490.HKD","IE0009355771.USD","LU1074936037.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666508051","title":"傳阿波羅(APO.US)擬接盤強生(JNJ.US)骨科業務 潛在交易估值近200億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2666508051","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666508051?lang=zh_tw&edition=fundamental","pubTime":"2026-09-12 11:04","pubTimestamp":1789182275,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，据媒体援引知情人士消息报道，全球另类资产管理公司阿波罗全球管理 正洽谈收购强生的骨科业务部门DePuy Synthes。这笔交易对该业务的估值可能接近200亿美元。强生的骨科业务部门DePuy Synthes主要生产关节植入物和手术器械，2025年创造了93亿美元的收入，但收入增速仅为1.1%。相比之下，强生2025年整体营收同比增长6%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1495305.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0912757837.SGD","IHE","IE0001KFT4U8.USD","BK4585","LU2756315318.SGD","LU2471134796.USD","BMED","IE000BZT7R73.USD","IE00B775SV38.USD","LU2468319806.SGD","LU2471134523.USD","GDOC","LU2129689431.USD","LU0545562505.USD","GPZ","LU0345769631.USD","LU1066051498.USD","MEDX","APO","IE000F7OJYX1.SGD","LU1989771016.USD","IYH","LU1668664300.SGD","LU1057294990.SGD","LU1244550494.USD","RXL","JNJ","LU1162221912.USD","IE00B42XCP33.USD","IXJ","LU1506573853.SGD","LU1032466523.USD","XLV","LU1267930813.SGD","LU2112291526.USD","LU2602419157.SGD","PRVT","FTXH","LU0006061336.USD","FHLC","AAUM","LU2487616109.SGD","TRUH","PJP","LU0689626769.HKD","IE00B3T34201.USD","IE00BGHQF631.EUR","LBO","VHT","JDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666778075","title":"據彭博社報導，阿波羅全球正就收購強生公司骨科業務部門進行談判","url":"https://stock-news.laohu8.com/highlight/detail?id=2666778075","media":"路透中文","labels":["corporation","merge","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666778075?lang=zh_tw&edition=fundamental","pubTime":"2026-09-12 06:42","pubTimestamp":1789166537,"startTime":"0","endTime":"0","summary":"据彭博社报导，阿波罗全球正就收购强生公司骨科业务部门进行谈判路透9月11日-据彭博社周五援引消息人士报导，阿波罗全球管理公司（Apollo Global Management，APO.N）正在就收购强生公司（Johnson & JohnsonJNJ.N）旗下骨科业务部门进行磋商，该交易可能使该业务部门的估值接近200亿美元。路透无法立即核实该报导。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260911:nL4T4531JU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1032955483.USD","IE00BSNM7G36.USD","LU1221951046.USD","LU1929549753.HKD","AAUM","IHE","LU1668664300.SGD","TRUH","IXJ","LU0345770993.USD","PJP","LU2112291526.USD","XLV","LU0985320562.USD","RXL","BK4007","BK4592","IYH","LU1430594728.SGD","GPZ","BK4588","APO","FHLC","LU0114720955.EUR","LU1551013342.USD","IE00BGHQF631.EUR","LBO","LU0234572021.USD","LU1778281490.HKD","LU2750360641.GBP","IE00BVYPNW00.USD","MEDX","LU0122379950.USD","LU1066051498.USD","GDOC","LU2471134523.USD","LU2487616109.SGD","JNJ","LU1228905540.USD","LU2347655156.SGD","LU1585245621.USD","BMED","VHT","LU2129689514.USD","FTXH","PRVT","LU0203347892.USD","LU1323610961.USD","JDOC","LU0795875086.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666577802","title":"據彭博社報道，阿波羅全球正就收購強生公司骨科業務部門進行談判","url":"https://stock-news.laohu8.com/highlight/detail?id=2666577802","media":"路透中文","labels":["corporation","merge","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666577802?lang=zh_tw&edition=fundamental","pubTime":"2026-09-12 06:42","pubTimestamp":1789166537,"startTime":"0","endTime":"0","summary":"据彭博社报道，阿波罗全球正就收购强生公司骨科业务部门进行谈判路透9月11日-据彭博社周五援引消息人士报道，阿波罗全球管理公司（Apollo Global Management，APO.N）正在就收购强生公司（Johnson & JohnsonJNJ.N）旗下骨科业务部门进行磋商，该交易可能使该业务部门的估值接近200亿美元。路透无法立即核实该报道。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260911:nL4S4531JU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VHT","IE00BKVL7J92.USD","LU2505996509.AUD","IXJ","XLV","LU0882574055.USD","BK4585","LU0964807845.USD","LU2112291526.USD","LU1196500208.SGD","LBO","LU0820562030.AUD","LU1506573853.SGD","RXL","LU1629891620.HKD","LU2756315664.SGD","LU0234570918.USD","LU1059921491.USD","AAUM","LU1935042991.SGD","LU1894683264.USD","FHLC","BMED","JNJ","LU1261432733.SGD","IE000F7OJYX1.SGD","BK4007","LU1989771016.USD","SG9999001176.USD","LU1221951129.SGD","LU1228905540.USD","TRUH","LU0792757196.USD","PJP","IHE","JDOC","MEDX","IE00BFXG1179.USD","PRVT","LU1043141396.HKD","GPZ","GDOC","IE00BGHQF631.EUR","BK4504","IYH","APO","LU0203345920.USD","IE000M9KFDE8.USD","FTXH","IE000MB6IJN5.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666657206","title":"據稱阿波羅正在洽談收購強生骨科業務部門。","url":"https://stock-news.laohu8.com/highlight/detail?id=2666657206","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666657206?lang=zh_tw&edition=fundamental","pubTime":"2026-09-12 06:25","pubTimestamp":1789165559,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE00BFXG1179.USD","RXL","LU0787776722.HKD","LU0795875086.SGD","LU1061106388.HKD","SGXZ57979304.SGD","LU0640476718.USD","LU0985320562.USD","LU1066051498.USD","IHE","LU2213496289.HKD","LU0943347566.SGD","IYH","LU0964807845.USD","LU2487616109.SGD","LU1057294990.SGD","IE00B1BXHZ80.USD","PJP","SG9999001176.USD","XLV","IE000SO60NU8.SGD","MEDX","SG9999001440.SGD","FTXH","IXJ","LU2133065610.SGD","BMED","LU0289739699.SGD","LU0210536198.USD","LU0345770308.USD","JDOC","LU2468319806.SGD","LU0345770993.USD","LU1244550221.USD","FHLC","JNJ","LU1732800096.USD","IE0000B7K699.USD","LU2750360997.AUD","GDOC","IE000WAW04H5.SGD","LU1221951046.USD","LU0689472784.USD","TRUH","VHT","IE00BGHQF631.EUR","IE00BZ1G4Q59.USD","LU0820562030.AUD","LU2756315664.SGD","SGXZ80539844.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154710349","title":"禮來完成對Ataibeckley收購，加速推進難治性抑鬱症及其他精神健康疾病療法研發","url":"https://stock-news.laohu8.com/highlight/detail?id=1154710349","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154710349?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 21:04","pubTimestamp":1789131857,"startTime":"0","endTime":"0","summary":"礼来公司已正式完成对Ataibeckley的收购事宜。这一战略举措，旨在为那些饱受难治性抑郁症以及其他精神健康疾病困扰的患者，开辟全新的治疗路径。此项交易的落定，标志着礼来在精神健康领域的布局迈出了坚实一步。礼来此番动作，显然意在突破这一瓶颈。通过将Ataibeckley的研发资产与专业团队纳入麾下，礼来有望整合各方资源，加速相关候选药物的研发进程。礼来此举，无疑将为其在精神科药物市场的未来竞争增添重要砝码。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0820561909.HKD","LU1868836591.USD","LU2271345857.HKD","IYH","LU0058720904.USD","LU0353189763.USD","LU0471298777.SGD","LU1093756168.USD","IE00BFSS7M15.SGD","LU1629891620.HKD","LU1814569148.SGD","LU2211815571.USD","SG9999014898.SGD","LU0820561818.USD","LU1023059063.AUD","IE0004445239.USD","LU2456880835.USD","TMED","CURE","LU2168564495.EUR","LU2471134879.HKD","IE00B4R5TH58.HKD","LU0006306889.USD","LU1623119135.USD","BK4516","LU2237443465.HKD","SG9999015986.USD","LU2491049909.HKD","VHT","LU1548497426.USD","LU1127390331.HKD","LU2552382132.HKD","LU1145028129.USD","LU0471298694.HKD","IHE","LU0823434583.USD","LU2236285917.USD","LU2491050071.SGD","LU2361045086.USD","SGXZ51526630.SGD","LU1064131342.USD","IE00BJT1NW94.SGD","LU0225283273.USD","LU0820562030.AUD","LU0708995401.HKD","LU0889565916.HKD","LU0354030511.USD","LU1232071149.USD","LU2168563687.JPY","LU2111349929.HKD","LU2237443549.SGD","HRTS","LU0256863902.USD","LU1035775433.USD","THNR","LU2324357040.USD","LU2106854487.HKD","LU2265009873.SGD","LU2756315664.SGD","SG9999015952.SGD","LU0256863811.USD","LU2462157665.USD","LU1093756325.SGD","IE00BWXC8680.SGD","LU2750360997.AUD","LU0096364046.USD","LU2023251221.USD","IXJ","LU0316494557.USD","LU1551013342.USD","IE00B1XK9C88.USD","IE00BK4W5L77.USD","LU2028103732.USD","LU2357305700.SGD","PPH","LU0289739699.SGD","LU1983299246.USD","LU0234572021.USD","LU0456855351.SGD","IE00BK4W5M84.HKD","LU0158827781.USD","LU2237443382.USD","LU2750360641.GBP","SG9999015978.USD","FTXH","LU0882574055.USD","MEDI","IE00BN29S564.USD","LLII","LU2361044865.SGD","LU0114720955.EUR","LU0786609619.USD","LU1291159041.SGD","LU2023250504.SGD","SG9999018857.SGD","BK4585","LU1989771016.USD","LU0323591593.USD","LU2063271972.USD","BK4588","LU0094547139.USD","LU2168564065.EUR","ELIL","LU2237443978.SGD","LU0079474960.USD","LU2360106947.USD","GDOC","LU0061475181.USD","LU0266013472.USD","LU2361044949.HKD","LU0109394709.USD","LU2108987350.USD","SG9999018865.SGD","LU0174119429.USD","SG9999014880.SGD","LU0823434740.USD","IE00B7KXQ091.USD","LU2168564222.USD","FHLC","IE00BKPKM429.USD","LU1366192091.USD","TRUH","SG9999001176.USD","LU1868837136.USD","RXL","LU0466842654.USD","IE00BJJMRX11.SGD","LU0683600562.USD","LU2089283258.USD","LU0158827948.USD","LU0943347566.SGD","LU1712237335.SGD","LU0203202063.USD","LU2462591350.SGD","SG9999017495.SGD","IE00B2B36J28.USD","LU0689472784.USD","IE00BJJMRY28.SGD","IE00BFSS8Q28.SGD","IE00B1BXHZ80.USD","LU0097036916.USD","ILDR","IE0004445015.USD","LU0640476718.USD","LU2417539215.USD","BK4007","AGNG","OZEM","PJP","LU0109391861.USD","LU2471134952.CNY","JDOC","LU0133085943.USD","IE0001KFT4U8.USD","LU2471134796.USD","LU0882574139.USD","LU1267930730.SGD","LU2746668461.USD","MHIP","SG9999013999.USD","CANC","LU2087625088.SGD","LU1974910355.USD","LU2756315318.SGD","BK4599","LU0345770993.USD","ELIS","LU1551013425.SGD","LU1917777945.USD","LU0417517546.SGD","LU1280957306.USD","SG9999015945.SGD","LU2264538146.SGD","LU0106261372.USD","SG9999014914.USD","LU2089984988.USD","IE0002141913.USD","LU0345770308.USD","LU2023250330.USD","LU2237443895.HKD","IE0005OL40V9.USD","LLYX","LU2168564149.EUR","SG9999001176.SGD","LU1988902786.USD","LU0385154629.USD","LU2896262040.SGD","LU1057294990.SGD","LU1720051017.SGD","IE00BKDWB100.SGD","WDNA","SGXZ57979304.SGD","IE00B4JS1V06.HKD","LU1868836914.USD","LU2237438978.USD","LU1804176565.USD","LLY","LU0787776722.HKD","MEDX","LU0122379950.USD","LU2468319806.SGD","SGXZ99366536.SGD","GB00BDT5M118.USD","BK4581","LU1061106388.HKD","SGXZ81514606.USD","LU2552382215.SGD","SG9999014906.USD","LU0320765992.SGD","LU0320765059.SGD","BK4533","LLYZ","LU1323610961.USD","LU0203201768.USD","IE00B775H168.HKD","LU1868837300.USD","SGXZ31699556.SGD","LU1720051108.HKD","LU0354030438.USD","LU2552382058.USD","IE00BJLML261.HKD","LU0432979614.USD","LU0823416689.USD","IE00BFTCPJ56.SGD","BK4534","LU0210536198.USD","LU0672654240.SGD","LU2602419157.SGD","LU2746668974.SGD","LU2237443622.USD","LU2471134523.USD","LU1868836757.USD","XLV","LU0353189680.USD","LU2112291526.USD","LU0198837287.USD","LU1979441026.SGD","LU1069344957.HKD","LU1691799644.USD","LU2213496289.HKD","LU2461242641.AUD","IE0009355771.USD","IE00BJJMRZ35.SGD","LU2491050154.USD","LU2089284900.SGD","LU0964807845.USD","LU0238689110.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114311100","title":"無AI增長：八大精選股票","url":"https://stock-news.laohu8.com/highlight/detail?id=1114311100","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114311100?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 13:06","pubTimestamp":1789103219,"startTime":"0","endTime":"0","summary":"人工智能究竟是一场第四次工业革命，还是一个超级泡沫？答案取决于你听的是华尔街哪位预言家的高论。它或将开启一个超级生产力周期，或将引发崩盘——亦或是两者兼而有之。它将攻克疾病与贫困，除非它先降低了大规模毁灭的门槛。有时实在令人疲惫不堪。以下八只颇具前景的股票，幸运地与AI关联甚微。没有事件视界，我们有的是一场盛大的电子游戏发布。我们不敢保证这份名单100%与AI绝缘。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2491050154.USD","LU1280957306.USD","IE00BJLML261.HKD","LU2896262040.SGD","SG9999015952.SGD","SGXZ51526630.SGD","LU2552382132.HKD","LU0122379950.USD","MEDX","LU0672654240.SGD","BK4516","LU2462157665.USD","LU2750360641.GBP","LU2361044949.HKD","LU0130102774.USD","LU2213496289.HKD","LU1861217088.USD","BK4599","IE00B4JS1V06.HKD","LU0109391861.USD","LU0094547139.USD","LU0289739699.SGD","SG9999014039.USD","LU2237438978.USD","IE00B775H168.HKD","LU2106854487.HKD","IE00B19Z3B42.SGD","LU2456880835.USD","LU1023059063.AUD","LU2237443895.HKD","LU0353189763.USD","LU2089284900.SGD","LU2089283258.USD","LU2360107671.USD","LU0234572021.USD","LU2237443622.USD","LU0708995401.HKD","LU2168563687.JPY","BK4007","LU0225284248.USD","LU2357305700.SGD","HRTS","SGXZ31699556.SGD","IE00B1BXHZ80.USD","LU0689472784.USD","LU1974910355.USD","LU2108987350.USD","LU0323591593.USD","LU0708994859.HKD","BK4142","LU1145028129.USD","IE0001KFT4U8.USD","LU2265009873.SGD","LU2552382215.SGD","LU2471134796.USD","LU1983299246.USD","IXJ","LU2111349929.HKD","IE00BKPKM429.USD","IE00BKDWB100.SGD","LU0971096721.USD","LU0225771236.USD","TRUH","IAI","LU0787776722.HKD","LU1069347547.HKD","IE0009355771.USD","LU0882574139.USD","IE00BWXC8680.SGD","LU2324357040.USD","LU2746668974.SGD","BK4589","LU2168564065.EUR","LU2750360997.AUD","IE00BFSS7M15.SGD","SG9999014013.SGD","LU1861220207.SGD","LU2237443978.SGD","MEDI","BMRN","LU1989771016.USD","LU0417517546.SGD","IE00BJT1NW94.SGD","LU2168564149.EUR","LU2746668461.USD","FHLC","LU1804176565.USD","LU2023250504.SGD","LU0742534661.SGD","LU0466842654.USD","LU0345774631.USD","IE00BK4W5M84.HKD","LU1153585028.USD","SG9999015986.USD","LU0203201768.USD","LU1791807156.HKD","BK4533","SG9999014005.SGD","LU2112291526.USD","SG9999018857.SGD","LU0109394709.USD","LU0114720955.EUR","LU2491049909.HKD","LU0385154629.USD","SCHW","LU0198837287.USD","LU0238689110.USD","LU2264538146.SGD","IE0004445239.USD","LU2471134952.CNY","LU1979441026.SGD","LU0432979614.USD","LU0823434583.USD","SG9999017495.SGD","LU0820562030.AUD","LU0820561818.USD","IE0002141913.USD","LU2087625088.SGD","BK4504","LU1069344957.HKD","LU1291159041.SGD","BK4139","LU1323610961.USD","SG9999013999.USD","LU0321505868.SGD","LU0128525929.USD","LU1267930730.SGD","LU1629891620.HKD","ILDR","LU1064131342.USD","LU1074936037.SGD","BK4585","FIVE","LU2168564495.EUR","LU2063271972.USD","LU1917777945.USD","BK4517","LU0306806265.USD","LU2417539215.USD","LU0471298777.SGD","IE00B19Z3581.USD","LU0985481810.HKD","LLII","SGXZ81514606.USD","LU2471134879.HKD","LU1548497426.USD","LU0256863811.USD","BK4588","LU1366192091.USD","IE0002270589.USD","LU0889565916.HKD","LU0256863902.USD","ELIL","LU2023250330.USD","LU2237443465.HKD","LU2168564222.USD","LU2756315318.SGD","SG9999014906.USD","LU1668664300.SGD","LU0058720904.USD","LU0106831901.USD","LU0306807586.USD","LU1061106388.HKD","CURE","LU0266013472.USD","LU1720051108.HKD","LU1868837300.USD","SGXZ57979304.SGD","LU1691799644.USD","RCL","LU1868836591.USD","LU1868837136.USD","LU2461242641.AUD","LU1035773651.USD","ELIS","LU1814569148.SGD","SG9999015945.SGD","LU0823416689.USD","LU0011850046.USD","SG9999015978.USD","RXL","LU0029864427.USD","LU0354030438.USD","LU1988902786.USD","WDNA","LLYX","LU1712237335.SGD","IE00B1XK9C88.USD","IE00BJJMRX11.SGD","BK4597","LU1093756325.SGD","LU0130517989.USD","LU2361044865.SGD","IE00B2B36J28.USD","LU0477156953.USD","LU2023251221.USD","LU1551013342.USD","LU0820561909.HKD","LU0471298694.HKD","SG9999014021.USD","LU0251142724.SGD","LU2471134523.USD","LU0079474960.USD","IHE","LU0345770308.USD","LU1232071149.USD","LU0316494557.USD","LU2552382058.USD","PPH","IE0005OL40V9.USD","IE00BFTCPJ56.SGD","LU0203202063.USD","SG9999001077.SGD","LU0683600562.USD","LU2028103732.USD","LU0640476718.USD","LU2089984988.USD","SG9999014898.SGD","IE00B7KXQ091.USD","LLYZ","LU1057294990.SGD","LU0210536198.USD","LU1670627923.USD","IE000M9KFDE8.USD","LU0345774391.USD","LU2236285917.USD","LU0353189680.USD","SG9999001176.SGD","SG9999018865.SGD","LU1127390331.HKD","LU1035775433.USD","FTXH","LU0980610538.SGD","LU0251131958.USD","SWK","BK4200","OZEM","LU2237443549.SGD","LU0096364046.USD","IYH","LU2211815571.USD","LU0786609619.USD","SG9999014914.USD","LU1093756168.USD","IE00BJJMRZ35.SGD","LU1868836914.USD","LU1623119135.USD","LU0310800379.SGD","BK4566","GDOC","LU0320765059.SGD","LU0106261372.USD","LU1720051017.SGD","LU2462591350.SGD","LU0345770993.USD","TMED","LU0964807845.USD","LU1267930573.SGD","LU0158827948.USD","SGXZ99366536.SGD","LU1670628061.USD","LU0158827781.USD","SG9999014880.SGD","LU1868836757.USD","LU0648001328.SGD","LU2237443382.USD","VHT","LU0456855351.SGD","JDOC","LLY","IE00BN29S564.USD","LU0354030511.USD","LU0133085943.USD","IE0004445015.USD","LU2491050071.SGD","THNR","LU2756315664.SGD","BK4161","IE00BK4W5L77.USD","LU0174119429.USD","BK4581","IE00B7SZLL34.SGD","SG9999001176.USD","LU1551013425.SGD","LU0823434740.USD","LU2361045086.USD","LU0225283273.USD","LU2468319806.SGD","LU0061475181.USD","LU2360106947.USD","LU1363072403.SGD","BK4127","XLV","LU0097036916.USD","LU2602419157.SGD","CANC","GB00BDT5M118.USD","WNDR","LU0321505439.SGD","IE00BJJMRY28.SGD","LU0006306889.USD","LU2271345857.HKD","MHIP","LU0882574055.USD","IE00BFSS8Q28.SGD","LU1201861249.SGD","AGNG","BK4534","LU0320765992.SGD","IE00B4R5TH58.HKD","LU0943347566.SGD","PJP","LU0048573561.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666103599","title":"媒體-禮來公司憑藉GLP-1帶來的意外之財，將用於推進女性健康業務——彭博社","url":"https://stock-news.laohu8.com/highlight/detail?id=2666103599","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666103599?lang=zh_tw&edition=fundamental","pubTime":"2026-09-10 21:54","pubTimestamp":1789048489,"startTime":"0","endTime":"0","summary":"媒体-礼来公司凭借GLP-1带来的意外之财，将用于推进女性健康业务——彭博社9月10日--- 来源链接： (link)https://tinyurl.com/327fb793-- 注：路透尚未核实此报道，也不对其准确性负责","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nL4S452151:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGXZ31699556.SGD","BK4534","SG9999014906.USD","LU1232071149.USD","SG9999015945.SGD","LU0787776722.HKD","LU0174119429.USD","TRUH","PPH","LU2237443978.SGD","LLII","LU1280957306.USD","LU0234572021.USD","LU1804176565.USD","LU0820562030.AUD","LU1974910355.USD","LU2471134952.CNY","LU2471134796.USD","LU0354030511.USD","LU2168564149.EUR","SGXZ51526630.SGD","IE00B2B36J28.USD","LU1057294990.SGD","LU2023251221.USD","LLYX","LU1061106388.HKD","LU0820561818.USD","IE0009355771.USD","LU0320765059.SGD","LU0210536198.USD","LU2756315318.SGD","LU2023250504.SGD","LU0266013472.USD","LU1868837300.USD","LU1989771016.USD","LU2361045086.USD","SGXZ99366536.SGD","LU0256863902.USD","IE00BWXC8680.SGD","LU0345770993.USD","LU0058720904.USD","SG9999015986.USD","LU0456855351.SGD","LU0823434740.USD","IE00BJT1NW94.SGD","BK4516","LU1868836757.USD","LU2089283258.USD","BK4588","LU2089284900.SGD","IE0002141913.USD","IE00B4JS1V06.HKD","LU0122379950.USD","LU1069344957.HKD","SG9999014914.USD","IE00BJJMRZ35.SGD","LU0889565916.HKD","LU2168563687.JPY","LU0289739699.SGD","LU2168564222.USD","LU2361044865.SGD","SG9999017495.SGD","BK4581","LU0354030438.USD","LU0708995401.HKD","LU2237443549.SGD","LU2417539215.USD","IE00BK4W5L77.USD","LU1868836591.USD","PJP","LU2028103732.USD","LU1551013425.SGD","LU0109391861.USD","MEDX","LU2213496289.HKD","THNR","LU0471298694.HKD","LU0096364046.USD","LU0323591593.USD","LU2106854487.HKD","LU2108987350.USD","SG9999001176.USD","SG9999014898.SGD","IE00BFSS7M15.SGD","LU1323610961.USD","SG9999018865.SGD","LU2324357040.USD","LU2357305700.SGD","LU0786609619.USD","LU1988902786.USD","LU0432979614.USD","LU2750360997.AUD","SGXZ81514606.USD","LU0006306889.USD","LU2237443382.USD","LU2237443465.HKD","LU0061475181.USD","LU2462157665.USD","LU0109394709.USD","IE00BKDWB100.SGD","VHT","LU0353189763.USD","LU0882574139.USD","LU0882574055.USD","LU2063271972.USD","LU2471134879.HKD","LU1291159041.SGD","LU2211815571.USD","LU2461242641.AUD","LU1023059063.AUD","LU1983299246.USD","LU1868836914.USD","AGNG","SG9999013999.USD","LU0964807845.USD","LU0238689110.USD","BK4533","TMED","LU0689472784.USD","LU2468319806.SGD","IE00BJLML261.HKD","BK4599","LU0114720955.EUR","LU0198837287.USD","ELIS","LU0225283273.USD","LU1979441026.SGD","LLY","SG9999001176.SGD","LU0158827948.USD","LU1712237335.SGD","FHLC","ILDR","LU0203201768.USD","LU1093756168.USD","LU1868837136.USD","LU2168564495.EUR","LU1366192091.USD","LU2237438978.USD","LU1814569148.SGD","SGXZ57979304.SGD","LU1917777945.USD","LU2023250330.USD","MEDI","LU0203202063.USD","LU0320765992.SGD","IE00BJJMRY28.SGD","IE00B4R5TH58.HKD","LU1720051108.HKD","LU2552382215.SGD","LU2264538146.SGD","LU2896262040.SGD","LU2552382058.USD","LU2746668974.SGD","SG9999015978.USD","LU0471298777.SGD","IE00BJJMRX11.SGD","LU2271345857.HKD","LU2491050154.USD","SG9999018857.SGD","LU2089984988.USD","HRTS","LU2746668461.USD","LU2360106947.USD","LU0097036916.USD","LU0820561909.HKD","IE00B1XK9C88.USD","LU0316494557.USD","IE00B7KXQ091.USD","LU0345770308.USD","LU0417517546.SGD","LU2111349929.HKD","LU0133085943.USD","LU0385154629.USD","IE00B1BXHZ80.USD","LU2462591350.SGD","LU0106261372.USD","IYH","ELIL","IE0004445239.USD","IE00BFTCPJ56.SGD","LU0158827781.USD","LU0466842654.USD","IHE","LU1691799644.USD","LU2237443895.HKD","LU2750360641.GBP","LU0353189680.USD","LU1623119135.USD","LU2471134523.USD","LU0094547139.USD","BK4007","SG9999014880.SGD","LU0640476718.USD","IE0004445015.USD","IE0005OL40V9.USD","LLYZ","LU1720051017.SGD","LU2491050071.SGD","LU1035775433.USD","LU1064131342.USD","GB00BDT5M118.USD","LU2602419157.SGD","OZEM","LU2265009873.SGD","SG9999015952.SGD","LU2456880835.USD","BK4585","CURE","LU0823416689.USD","LU1551013342.USD","LU2236285917.USD","LU1127390331.HKD","LU2112291526.USD","IE00BN29S564.USD","IE00B775H168.HKD","CANC","GDOC","IE00BKPKM429.USD","JDOC","LU0823434583.USD","LU2087625088.SGD","XLV","LU0672654240.SGD","LU1145028129.USD","LU0256863811.USD","WDNA","IE00BFSS8Q28.SGD","LU1093756325.SGD","FTXH","RXL","LU1267930730.SGD","LU1629891620.HKD","IXJ","LU0079474960.USD","LU0943347566.SGD","LU2491049909.HKD","LU0683600562.USD","IE00BK4W5M84.HKD","LU2168564065.EUR","LU2361044949.HKD","LU2552382132.HKD","MHIP","IE0001KFT4U8.USD","LU2237443622.USD","LU2756315664.SGD","LU1548497426.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666596063","title":"強生（JNJ）漲1.63% 新款雙周拋隱形眼鏡獲CE認證","url":"https://stock-news.laohu8.com/highlight/detail?id=2666596063","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666596063?lang=zh_tw&edition=fundamental","pubTime":"2026-09-10 21:21","pubTimestamp":1789046500,"startTime":"0","endTime":"0","summary":"金吾财讯 | 强生（JNJ）美股盘前股价震荡上行，最新涨1.63%，报271.4美元。消息面上，强生周四宣布，旗下新款ACUVUE OASYS MAX双周抛复用隐形眼镜已拿到CE认证。该款产品属于ACUVUE OASYS MAX产品线的新品，可在完整14天佩戴周期内保障佩戴舒适度与清晰视力。镜片搭载OptiBlue滤光技术、TearStable锁泪技术以及一类紫外线防护功能，专门面向长时间使用电子屏幕人群的用眼需求设计。上市节奏方面，计划2026年晚些时候率先登陆部分欧洲国家；后续视各地监管审批进度，在2027-2028年进一步拓展市场。目前该产品尚未取得美国FDA批准，暂未在美国市场销售。","market":"us","thumbnail":"https://static.szfiu.com/news/20250107/OGNjYWRkOTg0ZTNhODNlYjIwMzU4Nzc5OGE1MjIxNzAyOTY4ODU1OQ==.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/OGNjYWRkOTg0ZTNhODNlYjIwMzU4Nzc5OGE1MjIxNzAyOTY4ODU1OQ==.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"305910","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1674673428.USD","LU1066053197.SGD","IXJ","BK4581","JDOC","IE00BGHQF631.EUR","LU2750360997.AUD","LU1228905037.USD","PJP","LU0964807845.USD","IE00BDGV0183.EUR","VHT","LU1291159041.SGD","LU0345770993.USD","LU2750360641.GBP","FHLC","XLV","JNJ","BK4592","LU1732800096.USD","IHE","LU0124676726.USD","IE00BLSP4239.USD","LU1043141396.HKD","IE00BVYPNW00.USD","LU2756315664.SGD","LU2756315318.SGD","LU0792757196.USD","LU0070217475.USD","BMED","BK4559","GDOC","IE00BN8TJ469.HKD","SG9999001440.SGD","LU0689626769.HKD","LU1244550494.USD","LU2505996509.AUD","LU0820562030.AUD","FTXH","LU0820561909.HKD","TRUH","LU0345770308.USD","LU2133065610.SGD","MEDX","LU1929549753.HKD","BK4532","IYH","LU2456880835.USD","RXL","IE000BZT7R73.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666456659","title":"默沙東帕博利珠單抗三陰性乳腺癌適應症人群擴展在華獲批","url":"https://stock-news.laohu8.com/highlight/detail?id=2666456659","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666456659?lang=zh_tw&edition=fundamental","pubTime":"2026-09-10 16:21","pubTimestamp":1789028510,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1934455277.USD","LU2361044949.HKD","SG9999015341.SGD","LU1917777945.USD","LU1983299246.USD","SG9999014567.USD","IE0009355771.USD","LU0320765489.SGD","LU0868494617.USD","LU0098860793.USD","LU0965508806.USD","IE00BFTCPJ56.SGD","LU1934455194.USD","LU1989771016.USD","SG9999002224.SGD","LU1201861249.SGD","LU0203345920.USD","LU0965509010.AUD","LU1066051498.USD","LU2112291526.USD","LU2491050071.SGD","LU1974910355.USD","SG9999014559.SGD","IE00B1BXHZ80.USD","SG9999001440.SGD","SG9999002232.USD","LU1941712264.USD","LU0058720904.USD","LU2125909593.SGD","BK4585","FHLC","LU0859254822.USD","HRTS","IE000M9KFDE8.USD","LU1057294990.SGD","IE00BN8TJ469.HKD","LU0265550946.USD","BK4588","LU2468319806.SGD","IE0002141913.USD","LU0823416689.USD","LU0868494708.USD","TRUH","LU1989772840.SGD","LU2491050154.USD","LU0130517989.USD","LU0238689110.USD","LU0266013472.USD","IE00BLSP4239.USD","SG9999013999.USD","IE00BBT3K403.USD","LU1069347547.HKD","LU1035773651.USD","LU1116320737.USD","LU1571399168.USD","BK4550","LU0106261372.USD","LU0320765646.SGD","LU2461242641.AUD","FTXH","LU0965509101.SGD","LU1061106388.HKD","LU1066051811.HKD","IE00BSNM7G36.USD","RXL","LU1989772923.USD","LU1116320901.HKD","LU1923622614.USD","SG9999014542.SGD","XLV","LU2125154935.USD","JDOC","LU0130102774.USD","LU1430594728.SGD","IXJ","BK4559","IE00B2B36J28.USD","LU0985320562.USD","BK4007","LU2089984988.USD","LU2360032135.SGD","SG9999015358.SGD","IE00BLSP4452.SGD","IHE","LU0289739699.SGD","LU0432979614.USD","LU0124676726.USD","LU2023250504.SGD","LU1585245621.USD","LU0965509283.SGD","LU2357627491.SGD","LU2361044865.SGD","LU1093756168.USD","IYH","LU0265550359.USD","LU1162221912.USD","PPH","LU1037948541.HKD","LU2023250843.SGD","SG9999001176.USD","LU0006306889.USD","MRK","SGXZ57979304.SGD","VHT","LU2324357040.USD","LU0234572021.USD","GDOC","BK4516","LU0211331839.USD","LU2433249047.HKD","LU2125909247.SGD","PAWZ","LU0208291251.USD","LU1093756325.SGD","LU1699723380.USD","LU0070302665.USD","LU2361045086.USD","LU0980610538.SGD","LU2491049909.HKD","LU1934455863.HKD","LU1929549753.HKD","LU0122379950.USD","LU1291159041.SGD","LU0689626769.HKD","LU1023059063.AUD","LU1066053197.SGD","BK4533","LU0203347892.USD","LU0861579265.USD","LU1941712348.USD","LU2106854487.HKD","LU0648001328.SGD","LU2125154778.USD","LU0477156953.USD","LU1037948897.HKD","BK4534","IE00BJJMRZ35.SGD","SG9999001176.SGD","LU0942090050.USD","LU1032466523.USD","IE00BJT1NW94.SGD","SG9999014575.USD","IE00B4R5TH58.HKD","LU1066051225.USD","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666563124","title":"118款生物藥專利懸崖將至，中國藥企業迎戰MNC最大專利懸崖","url":"https://stock-news.laohu8.com/highlight/detail?id=2666563124","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666563124?lang=zh_tw&edition=fundamental","pubTime":"2026-09-10 15:26","pubTimestamp":1789025185,"startTime":"0","endTime":"0","summary":"BCG合伙人杜菁博士指出，未来几年全球MNC将迎来史上最大专利悬崖，有118种生物制剂将会失去相应的专利保护，涉及2340亿美元市场。然而，目前这118款即将到期分子中，只有极少数在火热开发，大量缺口有待生物类似药填补。目前来说，创新药出海还没办法完成这个闭环，但生物类似药作为先头部队做出海试验，企业风险和获益会更高。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1789025064363150858","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["BBH","IYH","FXH","MEDI","PBPH","PJP","PPH","APXH","JDOC","BBP","TRUH","159839","TMED","FHLC","RSPH","IHE","GSKH","BME"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666584416","title":"Leerink Partners上調默克目標價至161美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2666584416","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666584416?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 18:22","pubTimestamp":1788949320,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU2357627491.SGD","JDOC","LU0203345920.USD","LU0689626769.HKD","LU2106854487.HKD","LU2468319806.SGD","UUP","LU0965509101.SGD","LU0965509283.SGD","LU0648001328.SGD","GDOC","BK4534","LU1934455863.HKD","LU0098860793.USD","LU0980610538.SGD","IHE","IXJ","SG9999015358.SGD","FHLC","RXL","LU2125909247.SGD","SG9999014567.USD","MRK","LU1201861249.SGD","SGXZ57979304.SGD","LU1066051225.USD","IYH","SG9999014542.SGD","LU1035773651.USD","LU0234572021.USD","HRTS","LU0238689110.USD","LU2125909593.SGD","PAWZ","UDN","XLV","IE00BJT1NW94.SGD","LU2491049909.HKD","LU0868494708.USD","SG9999013999.USD","BMED","VHT","LU1941712264.USD","LU1430594728.SGD","PPH","TRUH","FTXH","LU1923622614.USD","IE00BLSP4239.USD","LU0122379950.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666137293","title":"百時美施貴寶(BMY)股票9月8日盤中下跌3.25%：真相來了","url":"https://stock-news.laohu8.com/highlight/detail?id=2666137293","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666137293?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 03:16","pubTimestamp":1788894989,"startTime":"0","endTime":"0","summary":"• 尽管 arlocabtagene autoleucel 的2期临床试验结果积极，百时美施贵宝仍面临获利回吐。\n• 由于监管时间表尚未明确以及近期临床试验暂停招募，投资者态度谨慎。\n• 该公司年收入为481.9亿美元，并维持着稳健的财务运营指标。","market":"hk","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262156751-market-movers-bmy-20260908","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1868836591.USD","IE00B2B36J28.USD","LU0096364046.USD","LU1236620834.HKD","LU1868836914.USD","LU0306806265.USD","LU2242652126.USD","BK4007","LU0456855351.SGD","BMY","FTXH","LU0882574055.USD","LU0985481810.HKD","LU0114720955.EUR","LU1291159041.SGD","LU1571399168.USD","LU1323610961.USD","IE00BSNM7G36.USD","BK4559","BK4585","LU1868837300.USD","LU1989771016.USD","IHE","LU2242646821.SGD","BK4588","LU0225771236.USD","BK4532","LU0061475181.USD","LU1236620750.USD","LU2596442595.SGD","LU0432979614.USD","LU1670710661.SGD","IE00BFTCPJ56.SGD","BK4534","IE00BJT1NW94.SGD","LU1430594728.SGD","LU1868836757.USD","IE0002141913.USD","LU1670710588.SGD","LU0225284248.USD","LU0868494617.USD","LU0267386448.USD","LU0321505868.SGD","IE0009355771.USD","LU0321505439.SGD","IE00BJJMRZ35.SGD","LU1718418525.SGD","LU2125154778.USD","LU0237698245.USD","LU2125154935.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666371445","title":"諾華公司一款降膽固醇藥物在臨床試驗中失敗，Royalty Pharma股價下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2666371445","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666371445?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 00:41","pubTimestamp":1788885660,"startTime":"0","endTime":"0","summary":"——Royalty Pharma** RPRX重申“其2030年投资组合收入目标为47亿美元或更高”** 计入本交易日涨幅，该股今年以来累计上涨54.7%","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nL4T4501DE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BFTCPJ56.SGD","BK4533","BK4581","IE00B2B36J28.USD","LU1983299246.USD","LU1023059063.AUD","IE00B4R5TH58.HKD","IE0002141913.USD","IHE","LU2112291526.USD","AMGN","LU1057294990.SGD","IBBQ","LU2242652126.USD","LU0109394709.USD","LU0889565916.HKD","LU1571399168.USD","BK4139","RPRX","SG9999001440.SGD","IBB","TBXU","LU0058720904.USD","LU0320765992.SGD","BK4566","BBH","IE00BJJMRZ35.SGD","BK4588","PBE","BK4599","BK4007","LU1061106388.HKD","PJP","BK4534","LU2242646821.SGD","BIB","BK4585","IE00BJT1NW94.SGD","LU2089984988.USD","LU0868494617.USD","LU0289739699.SGD","LU0122379950.USD","LU2468319806.SGD","IONS","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":200,"code":"91000000","status":"200"}]}}